- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05585112
Articaine 4% Versus Lidocaine 2% for Local Anesthesia of MIH-affected Maxillary Molars
Comparative Study of Articaine 4% Versus Lidocaine 2% in Local Anesthesia and Permanent Maxillary First Molars Affected by MIH.
Comparison of injection pain with lidocaine and articaine. Comparison of the efficacy of lidocaine and articaine during treatment of MIH- maxillary molars.
Design: A randomized, controlled, crossover, Triple-blinding clinical study including twenty six cooperative children, aged 6-12years old
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background and Aims: Some dentists have difficulty obtaining effective anesthesia when treating MIH molars.
There are no studies comparing the effectiveness of lidocaine and articaine in MIH-maxillary molars.
Design: A randomized, controlled, crossover, Triple-blinding clinical study including twenty six cooperative children , aged 6-12 years old. Each child was randomly assigned to either articaine 4% or lidocaine 2% in their first session with the second solution being used at the second session.
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Contact
- Name: Nabih Raslan, Dr
- Phone Number: 00963999140762
- Email: Raslan.nabih@tishreen.edu.sy
Study Contact Backup
- Name: Mai Haidar, Dr
- Phone Number: 00963991209347
- Email: mai.q.haidar@tishreen.edu.sy
Study Locations
-
-
-
Latakia, Syrian Arab Republic
- Tishreen University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Absolute positive or positive behavior according to the Frankel Scale.
- child is not under the effect of any analgesics or sedatives and their weight was more than 20 kg.
- Healthy, both physically and mentally
- A child with a MIH-affected maxillary permanent first molar on the right and left sides .
Exclusion Criteria:
- children who are uncooperative
- allergic anesthetics used in the study
- children who show inflammation in the injection site.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: A (Lidocaine 2%)
26 children will be injected with 1 ml of lidocaine 2% with epinephrine
|
The child will be injected with lidocaine 2%,after that the treatment will be completed , Pain during injection and treatment will be assessed using the FLACC scale and pain after injection and treatment will be evaluated using the Wong-Baker faces pain rating scale
Other Names:
|
Experimental: B (Articaine 4%)
26 children will be injected with 1 ml of Articaine 4% with epinephrine.
|
The child will be injected with 4% Articaine, after that the treatment will be completed , Pain during injection and treatment will be assessed using the FLACC scale and Wong-Baker faces pain rating scale
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
injection pain
Time Frame: during the injection of local anesthesia procedure
|
evaluated by outcome assessor using the Faces, Legs, Activity, Cry, Consolability Behavioral Pain Rating Scale ( FLACC scale ) ( a behavioral pain assessment scale which has five criteria face, legs, activity, cry, consolability ,which are each assigned a score of 0, 1 or 2.Total score of scale is summed in range 0 to 10, where: 0=relaxed and comfortable; 1-3=mild discomfort; 4-6=moderate pain; 7-10=severe pain)..
|
during the injection of local anesthesia procedure
|
injection pain
Time Frame: Immediately after the injection of local anesthesia procedure
|
self assessment pain by the children using Wong-Baker faces pain rating scale (a scale shows a series of faces ranging from a happy face at 0, or "no hurt", to a crying face at 10,which represents "hurts like the worst pain imaginable" )
|
Immediately after the injection of local anesthesia procedure
|
dental pain
Time Frame: during procedure
|
evaluated by outcome assessor using the Faces, Legs, Activity, Cry, Consolability Behavioral Pain Rating Scale ( FLACC scale ) ( a behavioral pain assessment scale which has five criteria face, legs, activity, cry, consolability ,which are each assigned a score of 0, 1 or 2.Total score of scale is summed in range 0 to 10, where: 0=relaxed and comfortable; 1-3=mild discomfort; 4-6=moderate pain; 7-10=severe pain)..
|
during procedure
|
dental pain
Time Frame: Immediately after treatment procedure
|
self assessment pain by the children using Wong-Baker faces pain rating scale (a scale shows a series of faces ranging from a happy face at 0, or "no hurt", to a crying face at 10,which represents "hurts like the worst pain imaginable" )
|
Immediately after treatment procedure
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mai Haidar, Dr, Tishreen University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Congenital Abnormalities
- Stomatognathic Diseases
- Tooth Diseases
- Stomatognathic System Abnormalities
- Tooth Abnormalities
- Dental Enamel Hypoplasia
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Membrane Transport Modulators
- Anesthetics, Local
- Voltage-Gated Sodium Channel Blockers
- Sodium Channel Blockers
- Lidocaine
- Carticaine
Other Study ID Numbers
- Tishreen U _Local anesthesia
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Molar Incisor Hypomineralisation
-
Sheffield Teaching Hospitals NHS Foundation TrustRecruitingMolar Incisor HypomineralisationUnited Kingdom
-
Tishreen UniversityCompletedMolar Incisor HypomineralisationSyrian Arab Republic
-
Assistance Publique - Hôpitaux de ParisCompletedDeep Caries | Molar Incisor HypomineralisationFrance
-
Marmara UniversityNot yet recruitingMolar-Incisor Hypomineralisation
-
Cairo UniversityCompletedHypomineralization of Enamel | Hypomineralization Molar IncisorEgypt
-
University of Nove de JulhoNot yet recruitingHypomineralization Molar Incisor
-
University of Nove de JulhoRecruiting
-
Marmara UniversityNot yet recruitingMolar-Incisor Hypomineralization
-
Marmara UniversityNot yet recruitingMolar-Incisor Hypomineralization
-
Universidade CeumaFundação de Amparo à Pesquisa e Desenvolvimento Científico do MaranhãoCompletedHypomineralization Molar IncisorBrazil
Clinical Trials on Lidocaine 2%
-
Ohio State UniversityCompleted
-
Monash UniversityRoyal Perth HospitalRecruitingBreast Cancer | Mastectomy | Breast Cancer Female | Breast Conserving SurgeryAustralia, New Zealand, Hong Kong
-
Khon Kaen UniversityNot yet recruitingIntubation | Hemodynamics | Laryngoscopy | Neurosurgery | LidocaineThailand
-
Khon Kaen UniversityCompleted
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedNeedlestick InjuriesNorway
-
University of Southern CaliforniaCompletedPelvic Floor DisordersUnited States
-
McMaster UniversitySt. Joseph's Healthcare HamiltonWithdrawnIntravenous Lidocaine for Post-Operative Pain Control in Patients Undergoing Bariatric Bowel SurgeryBariatric Surgery Candidate
-
Scilex Pharmaceuticals, Inc.Completed
-
Indonesia UniversityCompletedAnalgesia | Epidural; Anesthesia, HeadacheIndonesia
-
Mansoura UniversitySuspendedObesity | Bariatric Surgery CandidateEgypt